NCBiotech News

Three women from the North Carolina Biotechnology Center have been selected from among several thousand nominees as 2011 winners of Business Leader Media’s 10^th Annual Women Extraordinaire Awards, which honor top women business leaders of the South.

The Biotechnology Center is now accepting fellowship applications for the Industrial Fellowship program. This program provides North Carolina’s Ph.D. scientists with an opportunity to gain industry experience and companies to benefit from new talent and expertise. The program is for recent doctoral graduates and postdoctoral fellows who would like to transition from academia to permanent employment in the state’s life sciences industry.

North Carolina science educators and their students have a new way to stay informed about life-science businesses and activities around the state.

The quarterly life science magazine Impact, published in Charlotte, is now being mailed free to science teachers, guidance counselors and career and technical-education coordinators in North Carolina public and private high schools.

With ongoing rain and flooding from Hurricane Florence, NCBiotech is making the following changes to operating hours today, Monday September 17.

• Eastern office (Greenville) closed
• Greater Charlotte office closed
• Piedmont Triad office (Winston-Salem) closed
• Southeastern office (Wilmington) closed

Many of these office teams are working off-site, conditions permitting. You can likely reach them via email. Our RTP and Western (Asheville) offices are open regular hours. 

 

North Carolina entrepreneurs looking to validate and advance their business startup ideas are being encouraged to apply now through May 14 for NC IDEA’s new “no strings attached” SEED Micro-Grant Pilot Program.

Grifols, a Spanish biotherapeutics company that employs some 2,500 people in North Carolina, donated more than 25 million international units (IU) of blood clotting factor in 2017, as part of an eight-year commitment to changing the lives of people with hemophilia in 47 countries who have limited access to treatment.

Camras Vision, developer of a new medical device for treating glaucoma, won the Emerging Company Award at SEBIO’s 19th Annual Investor and Partnering Forum in Pinehurst. The honor came a few days before the company expects to close on $5 million in Series A financing.

Many of us chose a career in the life sciences to make a difference. To cure diseases. To improve the environment. To feed the world. But it’s easy to lose the big picture as we focus on the details of our daily routine.

North Carolina is one of five states consistently recognized for its specialized life science industry. The state’s strong network of life science companies, universities and skilled workforce provide a strong advantage for companies of all sizes and stages of development. Statewide, North Carolina has more than 700 life science companies with 63,000 employees, and employment within life sciences is growing at 6.6 percent – triple the national average.

North Carolina, rich in scientific expertise and supporting resources, is one of the nation’s best places to start a life science enterprise, a panel of early stage company entrepreneurs agreed at the CED Life Science Conference in Raleigh.

The price is right – free -- and the content is rich. It’s the newly published 2017-18 print edition of the NCBiotech Company Directory.

Fervent Pharmaceuticals of Greenville has successfully submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for FP-101, its proprietary lead drug candidate for treating menopause symptoms.

Fresenius Kabi will expand its drug-manufacturing operations in Wilson, potentially bringing at least 445 new jobs over five years and $100 million in investment.

Swiss-based Syngenta, which has its U.S. headquarters in Greensboro and its Advanced Crop Lab in Research Triangle Park, has obtained a non-exclusive license from the Broad Institute of MIT and Harvard to use CRISPR-Cas9 genome editing technology for agriculture applications.

The newly published 2016 Evidence and Opportunity: Impact of Life Sciences in North Carolina says the state now has over 650 life science companies that directly employ 63,000 people and account for 260,000 jobs overall, providing $2.2 billion in state and local tax revenues and $86 billion in total economic impact.